Imperial Brands Releases Study: Adult Smokers Reduced Cigarette Consumption After Using blu E-Cigarettes, with Flavours Playing a Key Role in Switching

Jun.17.2025
Two new studies from Imperial Brands show that adult smokers significantly reduced their cigarette use after switching to blu vapes, with flavors playing a key role.

[By 2Firsts] According to a study shared with 2Firsts by Imperial Brands, the company has carried out two new behavioural studies into its vape product, blu, showing how adult smokers use it in their daily lives to reduce – or even replace – cigarettes.

 

Imperial Brands’ behavioural scientists tracked adult smokers who had no plans to quit at the study outset, and found the following:

 

● After just one week, significant numbers of participants had shifted from smoking cigarettes to vaping blu – with an average fall in smoking rates of almost 29%.

 

● Vaping blu led to a sharp drop in how many cigarettes were smoked per day (an average of almost 30% across both studies).

 

● Authentic fruit and mint flavours were a crucial part of subjects’ switching journeys, helping them transition from smoking cigarettes to vaping blu – in one of the studies, almost 29% of subjects exclusively used fruit flavours.

 

● Flavours also encouraged subjects to continue vaping and not return to cigarettes – with 60% in one study saying they planned to purchase blu in the future because they liked the flavours offered.

 

● Longer term follow-up – around six months later – revealed that between a third and 40% of subjects had either significantly reduced smoking cigarettes, or even stopped completely.

 

Imperial Brands Releases Study: Adult Smokers Reduced Cigarette Consumption After Using blu E-Cigarettes, with Flavours Playing a Key Role in Switching
Study Results Released by Imperial Brands | Image Source: Imperial Brands Science

 

Elizabeth Clarke, Scientific Substantiation & Engagement Lead at Imperial Brands, commented:

 

“This latest consumer scientific research demonstrates blu’s exciting potential to help adult smokers either substantially reduce, or completely stop, using cigarettes. This is potentially extremely positive news for public health.

 

However, we’ve only scratched the surface of the rich insights from these studies. Scientists are currently analysing the data to find out more about individuals’ switching journeys.

 

The intention is to gain an even better understanding of consumer behaviour to inform future innovation pipelines and support adult smokers in their journeys to give up cigarettes.”

 

Thomas Nahde, Head of Harm Reduction & Engagement at Imperial Brands, added:

 

“Consumer preferences, next generation products, and the tobacco harm reduction debate itself continue to evolve at pace – and we are committed to ensuring the accompanying scientific research does too.

 

These behavioural studies demonstrate actual harm reduction. We’re excited to use the results to show that responsibly manufactured and marketed vapes – including blu – can help make a positive contribution to public health.”

 

Both studies are set to be submitted for publication in the peer-reviewed academic literature later this year. The study findings will also be presented in more detail at the Global Forum on Nicotine 2025 in Warsaw (19–21 June).

 

Imperial Brands states that it is committed to making a meaningful contribution to the public health concept of tobacco harm reduction (THR) through its next generation products (NGP).

 

The company previously conducted in-market research demonstrating how its heated tobacco system, PULZE & iD, helped adult subjects either substantially reduce – or even completely stop – smoking cigarettes.

 

A video of the in-market study featuring PULZE & iD is available online

 

The studies were conducted in collaboration with Russell Burnett Research and Consultancy Ltd (RBRC) and the Centre for Substance Use Research Ltd (CSUR).

 

Christopher Russell, Director of Russell Burnett Research and Consultancy, who led the studies, said: 

 

“The available evidence suggests that switching from cigarettes to e-vapor products can substantially reduce a person’s exposure to toxins that can cause cancer, lung disease, and heart disease. Results from these two studies demonstrate the potential for regular use of disposable or rechargeable blu vaping products for six weeks to help around 4-in-10 adults to either completely stop smoking or to cut the number of cigarettes they smoke each day by at least half. Indeed, some people cut their daily smoking in half within the first seven days of using blu products. Overall, these results indicate blu vaping products can make an important contribution to reducing adult smoking rates and the associated health consequences.”

 

Neil McKeganey, Director of Centre for Substance Use Research, said: 

 

“These studies were pioneering in a key respect. We gave each of our study participants a pre-funded personal debit card that they could use for six weeks solely to purchase blu vaping products from stores in their communities any time they wished. Participants were then completely free to choose whether they used these products, when and for how long they used them, and whether they continued to use these products beyond the study period. Our research showed that in the real-world circumstances of these individuals’ lives, blu vaping products were not only satisfying and appealing, but were an effective tool in enabling them to quit smoking.”

 


 

Note 1: 421 subjects; product was blu bar. Study 2: 429 subjects; product was blu 2.0. Research took place in London, UK and lasted 6 weeks, with follow-up at 24 weeks.

 

Note 2: In week 1 of the studies, the combined number of cigarettes smoked fell from a mean of 83.4 to 59.5 per participant.

 

Note 3: For the purposes of the studies, ‘substantial reductions’ was defined as a >50% reduction in cigarettes smoked per day.

Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
Florida Governor DeSantis Expands TANF Restrictions, Blocking Welfare Benefits From Buying Tobacco and Vapes
Florida Governor DeSantis Expands TANF Restrictions, Blocking Welfare Benefits From Buying Tobacco and Vapes
Florida Governor Ron DeSantis announced an expansion of Temporary Assistance for Needy Families (TANF) restrictions that would prohibit Electronic Benefit Transfer (EBT) funds from being used to purchase tobacco and vaping products. The state will amend its TANF State Plan and submit the changes for federal approval. Florida officials said the restrictions would not affect eligibility for temporary cash assistance or the amount of benefits received, but would change how funds can be spent.
Aug.25
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Alimentation Couche-Tard said U.S. same-store sales in its “other nicotine products” category grew at a double-digit rate in the first quarter of fiscal 2027, led by nicotine pouches, while overall U.S. same-store merchandise revenues increased 1.7%. The company also said its Canadian nicotine business continued to face regulatory pressure and illicit-market headwinds. The U.S. performance coincides with Couche-Tard's participation in efforts to reopen Canadian convenience-store access to authorized nicotine pouches, though the company has not established a direct causal link between the two.
Sep.14
Product | Philip Morris Korea Launches TEREA Limona Pearl, Expanding Fresh Blend Capsule Lineup to Five
Product | Philip Morris Korea Launches TEREA Limona Pearl, Expanding Fresh Blend Capsule Lineup to Five
Philip Morris Korea launched TEREA Limona Pearl in South Korea on August 31, 2026, expanding the TEREA Fresh Blend capsule tobacco stick lineup from four variants to five. Designed for the IQOS ILUMA series, the new stick combines a capsule with what the company calls a Fresh Filter. Philip Morris Korea describes the product as offering an aromatic, refreshing flavor profile with a cooling sensation, with an additional fresh note released when the capsule is crushed. The recommended retail price is KRW 4,800 per pack, with sales through IQOS stores and convenience stores nationwide. No reliable evidence has been found that the same Limona Pearl SKU was previously officially launched in another major IQOS market.
Sep.01
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30